Related references
Note: Only part of the references are listed.DPP4 deletion in adipose tissue improves hepatic insulin sensitivity in diet-induced obesity
Tapia Romacho et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2020)
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
Michael Letko et al.
NATURE MICROBIOLOGY (2020)
Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses
Furong Qi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Infection and Rapid Transmission of SARS-CoV-2 in Ferrets
Young-Il Kim et al.
CELL HOST & MICROBE (2020)
Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China
Bo Li et al.
CLINICAL RESEARCH IN CARDIOLOGY (2020)
Diabetes is a risk factor for the progression and prognosis of COVID-19
Weina Guo et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2020)
Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus
Hannah Kleine-Weber et al.
EMERGING MICROBES & INFECTIONS (2020)
Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes
Wei Zhang et al.
EMERGING MICROBES & INFECTIONS (2020)
Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis
Jing Yang et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19
Yong Gao et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis
Alfonso J. Rodriguez-Morales et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
Tao Chen et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Comorbidities and multi-organ injuries in the treatment of COVID-19
Tianbing Wang et al.
LANCET (2020)
COVID-19 and Italy: what next?
Andrea Remuzzi et al.
LANCET (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
Lei Fang et al.
LANCET RESPIRATORY MEDICINE (2020)
Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins
Tommy Tsan-Yuk Lam et al.
NATURE (2020)
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
Muthiah Vaduganathan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation
Arthur Simonnet et al.
OBESITY (2020)
Emerging COVID-19 coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26
Naveen Vankadari et al.
EMERGING MICROBES & INFECTIONS (2020)
Adenosine signaling and the immune system: When a lot could be too much
Luca Antonioli et al.
IMMUNOLOGY LETTERS (2019)
Mechanisms and pathways of anti-inflammatory activity of DPP-4 inhibitors in cardiovascular and renal protection
Katarina Tomovic et al.
MEDICINAL RESEARCH REVIEWS (2019)
Host Determinants of MERS-CoV Transmission and Pathogenesis
W. Widagdo et al.
VIRUSES-BASEL (2019)
Cardioprotection Conferred by Sitagliptin Is Associated with Reduced Cardiac Angiotensin II/Angiotensin-(1-7) Balance in Experimental Chronic Kidney Disease
Juliana Isa Beraldo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Clinical Use of DPP-4 Inhibitors
Baptist Gallwitz
FRONTIERS IN ENDOCRINOLOGY (2019)
Epigenetic regulation of hepatic Dpp4 expression in response to dietary protein
Sophie Saussenthaler et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2019)
Structures of MERS-CoV spike glycoprotein in complex with sialoside attachment receptors
Young-Jun Park et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2019)
Differential chemokine receptor expression and usage by pre-cDC1 and pre-cDC2
Stuart J. Cook et al.
IMMUNOLOGY AND CELL BIOLOGY (2018)
Efficacy and Safety of Teneligliptin in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Xiaoxuan Li et al.
FRONTIERS IN PHARMACOLOGY (2018)
Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance
Devram S. Ghorpade et al.
NATURE (2018)
Adaptive Evolution of MERS-CoV to Species Variation in DPP4
Michael Letko et al.
CELL REPORTS (2018)
Antidiabetic Drugs in NAFLD: The Accomplishment of Two Goals at Once?
Matteo Tacelli et al.
PHARMACEUTICALS (2018)
DPP4, the Middle East Respiratory Syndrome Coronavirus Receptor, is Upregulated in Lungs of Smokers and Chronic Obstructive Pulmonary Disease Patients
Leen J. M. Seys et al.
CLINICAL INFECTIOUS DISEASES (2018)
Hepatic DPP4 DNA Methylation Associates With Fatty Liver
Christian Baumeier et al.
DIABETES (2017)
Serum protease activity in chronic kidney disease patients: The GANI_MED renal cohort
Carmen Wolke et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2017)
Identification of senescent cell surface targetable protein DPP4
Kyoung Mi Kim et al.
GENES & DEVELOPMENT (2017)
Permissivity of Dipeptidyl Peptidase 4 Orthologs to Middle East Respiratory Syndrome Coronavirus Is Governed by Glycosylation and Other Complex Determinants
Kayla M. Peck et al.
JOURNAL OF VIROLOGY (2017)
Comparison of baseline characteristics and clinical course in Japanese patients with type 2 diabetes among whom different types of oral hypoglycemic agents were chosen by diabetes specialists as initial monotherapy (JDDM 42)
Kazuya Fujihara et al.
MEDICINE (2017)
Association of plasma dipeptidyl peptidase-4 activity with non-alcoholic fatty liver disease in nondiabetic Chinese population
Tianpeng Zheng et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2017)
Tissue Distribution of the MERS-Coronavirus Receptor in Bats
W. Widagdo et al.
SCIENTIFIC REPORTS (2017)
The tetraspanin CD9 facilitates MERS-coronavirus entry by scaffolding host cell receptors and proteases
James T. Earnest et al.
PLOS PATHOGENS (2017)
Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease
Christian Baumeier et al.
MOLECULAR METABOLISM (2017)
A Novel Dynamic Model Describing the Spread of the MERS-CoV and the Expression of Dipeptidyl Peptidase 4
Siming Tang et al.
COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE (2017)
Diabetes, hypertension, and chronic kidney disease progression: role of DPP4
Ravi Nistala et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2017)
Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model
Justin G. Julander et al.
ANTIVIRAL RESEARCH (2017)
Dipeptidyl Peptidase 4 Distribution in the Human Respiratory Tract Implications for the Middle East Respiratory Syndrome
David K. Meyerholz et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis
Alaa Badawi et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2016)
SARS and MERS: recent insights into emerging coronaviruses
Emmie de Wit et al.
NATURE REVIEWS MICROBIOLOGY (2016)
Viral Load Kinetics of MERS Coronavirus Infection
Myoung-don Oh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Editorial: The CXCr4 Ligand/Receptor Family and the DPP4 Protease in High-Risk Cardiovascular Patients
Heidi Noels et al.
FRONTIERS IN IMMUNOLOGY (2016)
Dipeptidyl peptidase-4 inhibition by Saxagliptin prevents inflammation and renal injury by targeting the Nlrp3/ASC inflammasome
Yochai Birnbaum et al.
BMJ OPEN DIABETES RESEARCH & CARE (2016)
Protease inhibitors targeting coronavirus and filovirus entry
Yanchen Zhou et al.
ANTIVIRAL RESEARCH (2015)
Reservoir Host Immune Responses to Emerging Zoonotic Viruses
Judith N. Mandl et al.
CELL (2015)
DPP4 in Cardiometabolic Disease Recent Insights From the Laboratory and Clinical Trials of DPP4 Inhibition
Jixin Zhong et al.
CIRCULATION RESEARCH (2015)
High expression of CD26 accurately identifies human bacteria-reactive MR1-restricted MAIT cells
Prabhat K. Sharma et al.
IMMUNOLOGY (2015)
Circulating dipeptidyl peptidase-4 activity correlates with measures of hepatocyte apoptosis and fibrosis in non-alcoholic fatty liver disease in type 2 diabetes mellitus and obesity: A dual cohort cross-sectional study
Kathryn H. Williams et al.
JOURNAL OF DIABETES (2015)
Sixteen-Years of Clinically Relevant Dipeptidyl Peptidase-IV(DPP-IV) Inhibitors for Treatment of Type-2 Diabetes: A Perspective
R. N. Kushwaha et al.
CURRENT MEDICINAL CHEMISTRY (2014)
Evidence for the antagonistic form of CXC-motif chemokine CXCL10 in serous epithelial ovarian tumours
Adam Rainczuk et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Adenosine Deaminase Acts as a Natural Antagonist for Dipeptidyl Peptidase 4-Mediated Entry of the Middle East Respiratory Syndrome Coronavirus
V. Stalin Raj et al.
JOURNAL OF VIROLOGY (2014)
Obese patients have higher circulating protein levels of dipeptidyl peptidase IV
Andreas Stengel et al.
PEPTIDES (2014)
Increased Plasma DPP4 Activity Is an Independent Predictor of the Onset of Metabolic Syndrome in Chinese over 4 Years: Result from the China National Diabetes and Metabolic Disorders Study
Fan Yang et al.
PLOS ONE (2014)
Therapeutic vaccine against DPP4 improves glucose metabolism in mice
Zhengda Pang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Novel Risk Loci for Rheumatoid Arthritis in Han Chinese and Congruence With Risk Variants in Europeans
Lei Jiang et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Proteolytic activation of the SARS-coronavirus spike protein: Cutting enzymes at the cutting edge of antiviral research
Graham Simmons et al.
ANTIVIRAL RESEARCH (2013)
CXCL10 antagonism and plasma sDPPIV correlate with increasing liver disease in chronic HCV genotype 4 infected patients
Dina Ragab et al.
CYTOKINE (2013)
A Potential Role for Dendritic Cell/Macrophage-Expressing DPP4 in Obesity-Induced Visceral Inflammation
Jixin Zhong et al.
DIABETES (2013)
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
V. Stalin Raj et al.
NATURE (2013)
Dipeptidyl peptidase-4: A key player in chronic liver disease
Minoru Itou et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Plasma dipeptidyl peptidase 4 activity correlates with body mass index and the plasma adiponectin concentration in healthy young people
Yasushi Kirino et al.
ENDOCRINE JOURNAL (2012)
Sitagliptin Exerts an Antinflammatory Action
Antoine Makdissi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Dipeptidyl Peptidase 4 Is a Novel Adipokine Potentially Linking Obesity to the Metabolic Syndrome
Daniela Lamers et al.
DIABETES (2011)
Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV
Armanda Casrouge et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response
Ilona Glowacka et al.
JOURNAL OF VIROLOGY (2011)
Soluble CD26/Dipeptidyl Peptidase IV Enhances Human Lymphocyte Proliferation In Vitro Independent of Dipeptidyl Peptidase Enzyme Activity and Adenosine Deaminase Binding
D. M. T. Yu et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2011)
Inhibitor selectivity in the clinical application of dipeptidyl peptidase-4 inhibition
Mark Kirby et al.
CLINICAL SCIENCE (2010)
The challenge of developing novel pharmacological therapies for non-alcoholic steatohepatitis
Detlef Schuppan et al.
LIVER INTERNATIONAL (2010)
Redefining Chronic Viral Infection
Herbert W. Virgin et al.
CELL (2009)
Alanine Aminopeptidase and Dipeptidyl Peptidase IV in Saliva of Chronic Periodontitis Patients
Piyamas Aemaimanan et al.
JOURNAL OF PERIODONTOLOGY (2009)
Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders
MD Gorrell
CLINICAL SCIENCE (2005)
Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2 (ACE2)
KF To et al.
JOURNAL OF PATHOLOGY (2004)
Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003
NS Zhong et al.
LANCET (2003)
CD26: A multifunctional integral membrane and secreted protein of activated lymphocytes
MD Gorrell et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2001)
Share Paper
